Related Experiment Video
Updated: Oct 12, 2026

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
Published on: May 21, 2013
A high molecular weight collagenase inhibitor made by rabbit chondrocytes in cell culture
1Department of Pharmacology, State University of New York, Stony Brook 11794-8651.
Abstract:
A new, high molecular weight (66,000 daltons) inhibitor of collagenase (LCI) has been isolated and partially characterized. It accounted for 20% of the collagenase-inhibitory activity in the supernatants of rabbit chondrocytes cultured in 10% acid-treated fetal bovine serum (ATFBS). LCI was stable to 60 degrees C and sensitive to reduction and alkylation. Unlike a low molecular weight collagenase inhibitor, similar to Tissue Inhibitor of Metallo-Proteinases (TIMP), it did not bind to concanavalin A-Sepharose 4B.
Insights
Researchers discovered a novel high molecular weight collagenase inhibitor (LCI) in rabbit chondrocytes. This LCI, distinct from TIMP, shows unique properties and contributes significantly to collagenase inhibition.
Area of Science:
- Biochemistry
- Cell Biology
- Enzymology
Background:
- Collagenase plays a crucial role in extracellular matrix degradation.
- Inhibitors of collagenase are important for understanding and treating diseases involving matrix remodeling.
- Rabbit chondrocytes are a relevant model for studying cartilage metabolism and matrix-associated enzymes.
Purpose of the Study:
- To isolate and characterize a novel high molecular weight collagenase inhibitor (LCI) from rabbit chondrocytes.
- To compare the properties of LCI with known collagenase inhibitors, such as Tissue Inhibitor of Metallo-Proteinases (TIMP).
- To determine the contribution of LCI to the overall collagenase inhibitory activity in cultured chondrocytes.
Main Methods:
- Isolation and partial characterization of a high molecular weight protein from rabbit chondrocyte culture supernatants.
- Assay of collagenase inhibitory activity.
- Stability studies (heat, reduction, alkylation).
- Chromatographic binding studies (concanavalin A-Sepharose 4B).
Main Results:
- A new, high molecular weight (66,000 daltons) collagenase inhibitor (LCI) was isolated.
- LCI accounted for 20% of the collagenase-inhibitory activity in supernatants from chondrocytes cultured in acid-treated fetal bovine serum.
- LCI was stable at 60°C but sensitive to reduction and alkylation.
- LCI did not bind to concanavalin A-Sepharose 4B, differentiating it from a low molecular weight inhibitor resembling TIMP.
Conclusions:
- A novel high molecular weight collagenase inhibitor (LCI) has been identified in rabbit chondrocytes.
- LCI possesses distinct biochemical properties compared to TIMP.
- This finding expands the understanding of collagenase regulation in cartilage and potentially other tissues.

